Table 2.
International price comparison of Korea’s reimbursement drug (USD PPP).
| Countries | Bedaquiline | Delamanid | Blinatumomab | Olaratumab | Reference | |
|---|---|---|---|---|---|---|
| US | Redbook | 191 (1.1) | – | 4,449 (1.6) | 57.8 (2.4) | Ex-factory pharmacy price |
| FSS | – | – | 2,385 (0.8) | 36.0 (1.5) | Contact price for government | |
| UK | 141 (0.8) | 37 (0.8) | 2,867 (1.0) | 54.0 (2.2) | Ex-factory pharmacy price | |
| France | – | 37 (0.8) | 3,293 (1.2) | – | Ex-factory wholesale price | |
| Italy | 150 (0.8) | 39 (0.9) | 3,582 (1.3) | 34.9 (1.4) | Ex-factory wholesale price | |
| Swiss | – | – | 2,321 (0.8) | – | Ex-factory wholesale price | |
| Germany | 180 (1.0) | 38 (0.8) | 2,864 (1.0) | 32.6 (1.3) | Ex-factory wholesale price | |
| Japan | – | 62 (1.4) | – | – | Ex-factory pharmacy price | |
| Australia | – | – | 2,724 (1.0) | – | Dispensed price for max amount | |
| Korea | 180 (1) | 45 (1) | 2,822 (1) | 24.2 (1) | Ex-factory pharmacy price | |